Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New thrombin inhibitors under study at Merck & Co.

Dec. 9, 1996

Novo Nordisk claims dopamine D3 receptor ligands for CNS indications

Dec. 9, 1996

Bayer reveals sugar-modified cytostatic agents

Dec. 9, 1996

New calcimimetic agents from ZymoGenetics

Dec. 9, 1996

Novel diagnostic agents for spongiform encephalopathies reported

Dec. 9, 1996

Pharmacia & Upjohn, McGill University claim antiparasitic MAb

Dec. 9, 1996

New analgesic compounds with novel mechanism of action disclosed by Novo Nordisk

Dec. 6, 1996

Japanese researchers disclose substance P antagonists

Dec. 5, 1996

Antitumor enhancers claimed by Taiho

Dec. 5, 1996

RPR continues research into taxanes

Dec. 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...